Ben Ho Park

21.8k citations

142 papers · 8.0k indexed · 4 hit papers · h-index 43

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Oncology top 1%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis

Papers in

Cancer Research 63
- Cancer Genomics and Diagnostics 46
- Breast Cancer Treatment Studies 13
Oncology 50
- HER2/EGFR in Cancer Research 12

Co-authors: Bert Vogelstein Kenneth W. Kinzler Kurtis E. Bachman Abde M. Abukhdeir Jian Yu Lin Zhang Ina Rhee Stephen B. Baylin
Journals: Cancer Research (12 papers)Journal of Clinical Oncology (12 papers)Clinical Cancer Research (8 papers)Proceedings of the National Academy of Sciences (7 papers)Cancer Biology & Therapy (6 papers)
Partner nations: United States Italy Canada

In The Last Decade

Ben Ho Park

134 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Male breast cancer: a disease distinct from female breast cancer 2018 · 230 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Breast Cancer Research and Treatment
2004 Cancer Biology & Therapy
2002 Nature
2000 Science

Peers

Countries citing papers authored by Ben Ho Park

Since Specialization

Citations

This map shows the geographic impact of Ben Ho Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Ho Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Ho Park more than expected).

Fields of papers citing papers by Ben Ho Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Ho Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Ho Park. The network helps show where Ben Ho Park may publish in the future.

Co-authors

The 25 scholars most cited alongside Ben Ho Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben Ho Park Line = papers co-authored together Ben Ho Park links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual Inhibition Molecular & Cellular Proteomics ·Qiong Wang, Xiangyi Kong, Hongming Song, Li Wang, Lingrui Li, Xiaonan Hou, Santosh Renuse, Muhammad Saddiq Zahari, Ran Cheng, Mahmood Khan, Jidong Wang, Kiran K. Mangalaparthi, Fang Lin, Tamara L. Lotan, Ben Ho Park, S. John Weroha, Huaijun Zhou, Akhilesh Pandey, Xinyan Wu	2025	0
2	An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release Communications Biology ·Brad A. Davidson, Adam X. Miranda, Sarah C. Reed, Riley E. Bergman, Justin Kemp, Anvith P. Reddy, Morgan V. Pantone, Ethan K. Fox, Rodney Dixon Dorand, Paula J. Hurley, Sarah Croessmann, Ben Ho Park	2024	9
3	Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy–Induced Necrosis Cancer Research ·Santanu Ghosh, Rachel Yang, Darjan Duraki, Junyao Zhu, Ji Eun Kim, Musarrat Jabeen, Chengjian Mao, Xinyi Dai, Mara R. Livezey, Matthew W. Boudreau, Ben Ho Park, Erik R. Nelson, Paul J. Hergenrother, David J. Shapiro	2023	15
4	Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy Molecular Cancer Research ·Qianying Zuo, Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich, Ozan Berk Imir, Eylem Kulkoyluoglu‐Cotul, Nicole Hwajin Park, David J. Shapiro, Ben Ho Park, Yvonne Ziegler, Benita S. Katzenellenbogen, Evelyn Aranda, John D. O’Neill, Akshara Singareeka Raghavendra, Debu Tripathy, Zeynep Madak‐Erdogan	2022	15
5	Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer JCO Precision Oncology ·Minetta C. Liu, Matthew MacKay, Matthew Kase, Aneta Piwowarczyk, Christine Lo, Jeff Schaeffer, Justin D. Finkle, Christopher E. Mason, Nike Beaubier, Kimberly Blackwell, Ben Ho Park	2022	16
6	Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes Clinical Breast Cancer ·Elaine M. Walsh, Neha Mangini, John H. Fetting, Deborah K. Armstrong, Isaac S. Chan, Roisín M. Connolly, Katie Fiallos, Jennifer Lehman, Raquel Nunes, Dana Petry, Jeffrey Reynolds, Mirat Shah, Karen L. Smith, Kala Visvanathan, Josh Lauring, Ben Ho Park, Vered Stearns, Antonio C. Wolff	2021	8
7	Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair Communications Biology ·Justin Zonneville, Moyi Wang, Mohammed Alruwaili, Brandon E. Smith, Megan Melnick, Kevin H. Eng, Thomas Melendy, Ben Ho Park, Renuka Iyer, Christos Fountzilas, Andrei V. Bakin	2021	8
8	Undetectable Tumor Cell-Free DNA in a Patient With Metastatic Breast Cancer With Complete Response and Long-Term Remission Journal of the National Comprehensive Cancer Network ·Natasha Hunter, Sarah Croessmann, Karen Cravero, Daniel Shinn, Paula J. Hurley, Ben Ho Park	2020	3
9	Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer Clinical Cancer Research ·Fei Wang, Sonya Reid, Wei Zheng, Tuya Pal, Ingrid M. Meszoely, Ingrid A. Mayer, Christina E. Bailey, Ben Ho Park, Xiao‐Ou Shu	2019	12
10	Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression Cancer Research ·Robert M. Hughes, Brian W. Simons, Hamda Khan, Rebecca L. Miller, Valentina Kugler, Samantha Torquato, Debebe Theodros, Michael C. Haffner, Tamara L. Lotan, Jessie Huang, Elai Davicioni, Steven S. An, Ryan C. Riddle, Daniel L.J. Thorek, Isla P. Garraway, Elana J. Fertig, John T. Isaacs, W. Nathaniel Brennen, Ben Ho Park, Paula J. Hurley	2019	52
11	Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations Cancer Letters ·Liqun Yu, Lawrence Wang, Chengjian Mao, Darjan Duraki, Ji Eun Kim, Rui Huang, William G. Helferich, Erik R. Nelson, Ben Ho Park, David J. Shapiro	2018	23
12	Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors Cancer Research ·Yuechao Zhao, Mary J. Laws, Valeria Sanabria Guillen, Yvonne Ziegler, Jian Min, Abhishek Sharma, Sung Hoon Kim, David Chu, Ben Ho Park, Steffi Oesterreich, Chengjian Mao, David J. Shapiro, K.W. Nettles, John A. Katzenellenbogen, Benita S. Katzenellenbogen	2017	44
13	Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine Clinical Cancer Research ·Hatim Husain, Vladislava O. Melnikova, Karena Kosco, Brian Woodward, Soham More, Sandeep C. Pingle, Elizabeth Weihe, Ben Ho Park, Muneesh Tewari, Mark G. Erlander, Ezra E.W. Cohen, Scott M. Lippman, Razelle Kurzrock	2017	106
14	Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component Clinical Cancer Research ·Bracha Erlanger Avigdor, Katie Beierl, Christopher D. Gocke, Daniel J. Zabransky, Karen Cravero, Kelly Kyker‐Snowman, Berry Button, David Chu, Sarah Croessmann, Rory L. Cochran, Roisín M. Connolly, Ben Ho Park, Sarah J. Wheelan, Ashley Cimino‐Mathews	2017	29
15	BRCA1 Deficiency Exacerbates Estrogen-Induced DNA Damage and Genomic Instability Cancer Research ·Kienan I. Savage, Kyle B. Matchett, Eliana M. Barros, K Cooper, Gareth Irwin, Julia J. Gorski, Katy S. Orr, Jekaterina Vohhodina, Joy N. Kavanagh, Angelina F. Madden, Alexander J. Powell, Lorenzo Manti, Simon S. McDade, Ben Ho Park, Kevin M. Prise, Stuart McIntosh, Manuel Salto‐Tellez, Derek J. Richard, Christopher T. Elliott, D. Paul Harkin	2014	8
16	PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System Clinical Cancer Research ·Julia A. Beaver, John P. Gustin, Kyung Hee Yi, Anandita Rajpurohit, Matthew C. Thomas, Samuel F. Gilbert, David Rosen, Ben Ho Park, Josh Lauring	2013	76
17	mTOR Signaling Feedback Modulates Mammary Epithelial Differentiation and Restrains Invasion Downstream of PTEN Loss Cancer Research ·Susmita Ghosh, Lidenys Varela, Anil K. Sood, Ben Ho Park, Tamara L. Lotan	2013	11
18	PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients Clinical Cancer Research ·Tamara L. Lotan, Bora Gürel, Siobhan Sutcliffe, David Esopi, Wennuan Liu, Jianfeng Xu, Jessica Hicks, Ben Ho Park, Elizabeth B. Humphreys, Alan W. Partin, Misop Han, George J. Netto, William B. Isaacs, Angelo M. De Marzo	2011	262
19	Deletion of PTEN Promotes Tumorigenic Signaling, Resistance to Anoikis, and Altered Response to Chemotherapeutic Agents in Human Mammary Epithelial Cells Cancer Research ·Michele Vítolo, Michele B. Weiss, Marta Szmacinski, Khola Tahir, Todd Waldman, Ben Ho Park, Stuart S. Martin, David J. Weber, Kurtis E. Bachman	2009	74
20	Knock-in of Mutant K- ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K- ras –Mediated Transformation Cancer Research ·Hiroyuki Konishi, Bedri Karakas, Abde M. Abukhdeir, Josh Lauring, John P. Gustin, Joseph P. Garay, Yuko Konishi, Eike Gallmeier, Kurtis E. Bachman, Ben Ho Park	2007	74

About Ben Ho Park

Ben Ho Park is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 142 papers that have together received 8.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (46 papers), PI3K/AKT/mTOR signaling in cancer (21 papers), Genetic factors in colorectal cancer (18 papers), BRCA gene mutations in cancer (14 papers), Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (12 papers), Estrogen and related hormone effects (12 papers) and Advanced Breast Cancer Therapies (12 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (2.5k citations), Molecular Biology (5.2k citations), Pulmonary and Respiratory Medicine (1.5k citations) and Genetics (1.1k citations). Ben Ho Park has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Bert Vogelstein, Kenneth W. Kinzler, Kurtis E. Bachman, Abde M. Abukhdeir, Jian Yu, Lin Zhang, Ina Rhee, Stephen B. Baylin, Josh Lauring and Hengmi Cui. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Proceedings of the National Academy of Sciences and Cancer Biology & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact